Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
17.12.25
/
50%
€5.85
Target price
17.12.26
-
Performance (%)
5.98%
Price
30.12.25
€6.20
Summary
This prediction is currently active. With a performance of 5.98%, the BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals is trending in the right direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vanda Pharmaceuticals | 6.897% |
| iShares Core DAX® | 0.794% |
| iShares Nasdaq 100 | 0.016% |
| iShares Nikkei 225® | 0.309% |
| iShares S&P 500 | 0.181% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.82
30.10.25
30.10.25
€9.47
30.10.26
30.10.26
62.30%
30.12.25
30.12.25
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
74.16%
30.12.25
30.12.25
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25

